STOCKHOLM, SWEDEN / RankWire.AI / – The 2026 Nobel Prize in Physiology or Medicine has been awarded to Karl Deisseroth, Peter Hegemann, and Georg Nagel for their pioneering discoveries that led to the creation of optogenetics. The Nobel Assembly at Karolinska Institutet announced this recognition on October 5. Their research demonstrated how proteins sensitive to light can be used to precisely manipulate nerve-cell activity, providing scientists with a direct method to investigate how specific brain circuits influence behaviour, memory, and emotion.
Hegemann and Nagel traced this innovative approach back to channelrhodopsin, a light-reactive protein identified in the single-celled alga Chlamydomonas. When illuminated with blue light, the protein opens a channel that allows charged ions to flow into the cell, potentially triggering an electrical impulse. They also proved that cells expressing channelrhodopsin could be made responsive to light, marking a crucial step towards employing the protein as a biological switch. Their work linked a fundamental biological response to a versatile tool that could be adapted for various cell types.
Deisseroth then adapted this breakthrough for neuroscience, introducing the gene encoding channelrhodopsin into rat nerve cells and employing blue light to activate nerve signals. His findings were first published in 2005, and by 2007, his team demonstrated that the light-controlled switch could function within the brains of living mice. These advances established optogenetics as an effective technique for studying neural circuits with high precision in controlling specific nerve cells.
From algae protein to a tool for neuroscience
Optogenetics merges genetic targeting with light stimulation to either activate or inhibit selected cells. Researchers utilize this method to explore the roles of particular nerve-cell groups during distinct behaviours or brain functions. The Nobel Assembly at Karolinska Institutet emphasized that this method has revolutionized the way scientists investigate the living brain. Laboratories globally now employ optogenetics to map neural circuits associated with movement, learning, memory, emotion, and other essential functions. The technique also enables researchers to directly link changes in specific cells to observable effects in living animals.
Further, scientists have applied optogenetics to investigate various neurological and psychiatric conditions. Studies have focused on brain circuits involved in Parkinson’s disease, epilepsy, depression, addiction, and other disorders. Additionally, clinical researchers are testing related approaches aimed at restoring vision in individuals with severe visual impairments. While these medical applications remain in experimental stages, the method’s most significant impact is as a research tool to understand cell and circuit functions, allowing for controlled light stimulation in the study of neural pathways across neuroscience.
Three scientists share the 2026 accolade
Deisseroth holds a professorship at Stanford University and is an investigator with the Howard Hughes Medical Institute in the U.S. Hegemann is affiliated with Humboldt University of Berlin, while Nagel works at the University of Würzburg in Germany. The three laureates will divide the 12 million Swedish kronor prize. The medicine award initiated the 2026 Nobel announcement series, which continues with prizes in physics, chemistry, literature, peace, and economic sciences. Each scientist’s contributions marked an essential step in the evolution of modern optogenetics.
This Nobel recognition underscores a series of discoveries that connected fundamental research on algae to a widely adopted technique in contemporary neuroscience. Channelrhodopsin provided the light-sensitive molecular switch, which was later refined to enable precise control of nerve cells. Today, optogenetics is utilized across various fields within biology and neuroscience. The laureates will receive their Nobel medals and diplomas at the Stockholm ceremony on December 10, coinciding with the anniversary of Alfred Nobel’s death and maintaining the traditional Nobel presentation format.